Scarring Due to Treatment Clinical Trial
Official title:
Efficacy of Silicone Gel Versus Placebo for Postsurgical Scars of the Eyelid
Verified date | June 2024 |
Source | Montefiore Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine whether silicone gel is effective at preventing or minimizing scar formation after eyelid surgery.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 11, 2024 |
Est. primary completion date | January 11, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients will be included if they have met the criteria for undergoing upper eyelid ptosis repair or blepharoplasty. This means they have droopiness of the upper eyelids that is visually significant and limiting the patient's visual field. Exclusion Criteria: - Patients will be excluded if they require additional upper eyelid surgery. |
Country | Name | City | State |
---|---|---|---|
United States | Montefiore Medical Center | Bronx | New York |
Lead Sponsor | Collaborator |
---|---|
Montefiore Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The appearance of post-operative scarring as graded by a blinded third-party physician using a questionnaire | To determine whether silicone gel is effective at preventing or minimizing scar formation after eyelid surgery. | 2 years | |
Secondary | Rates of patient satisfaction with their post-operative scars as assessed by a questionnaire | To determine whether silicone gel treatment has any effect on patient satisfaction with post-surgical eyelid scars. | 2 years |